| Japanese Journal of Clinical Oncology | Pages |
Letter
To the Editor:
I have enjoyed a fruitful and very positive experience learning
many different aspects of clinical practice and multimodality
management of non-small cell lung cancer patients (NSCLC),
which will be very useful to think over now that I have returned
home. First of all, on behalf of the Spanish Lung Cancer Group
I would like to say many thanks for giving me the opportunity and
honor of this fellowship. We spent a lot of time discussing
different approaches mainly for stage IIIAN2 disease and a lot of
pros and cons on the issue of whether